CytRx Corp
CYTR
CYTR was delisted on the 3rd of June, 2019.
72 hedge funds and large institutions have $41.6M invested in CytRx Corp in 2016 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 25 increasing their positions, 16 reducing their positions, and 6 closing their positions.
117% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 6
56% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 16
9% more funds holding
Funds holding: 66 → 72 (+6)
14% less capital invested
Capital invested by funds: $48.7M → $41.6M (-$7.06M)
23% less call options, than puts
Call options by funds: $860K | Put options by funds: $1.11M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$392K |
| 2 |
Group One Trading
Chicago,
Illinois
|
+$277K |
| 3 |
HCM
Highbridge Capital Management
New York
|
+$247K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$150K |
| 5 |
Goldman Sachs
New York
|
+$127K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QF
QVT Financial
New York
|
-$1.18M |
| 2 |
D.E. Shaw & Co
New York
|
-$187K |
| 3 |
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
|
-$155K |
| 4 |
Citigroup
New York
|
-$133K |
| 5 |
RI
RTW Investments
New York
|
-$130K |
CYTR Hedge Fund Activity: Q2 2016 in Review
72 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in CytRx Corp (CYTR) for Q2 2016, worth a combined $41.6M — down 14% from $48.7M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new CYTR positions and 6 closed out — a net gain of 7 holders — while 25 added to existing stakes and 16 trimmed.
The largest buyer was Vanguard Group, adding an estimated $392K. The largest seller was QVT Financial, cutting an estimated $1.18M.
- 72 institutional investors held CytRx Corp (CYTR) as of Q2 2016, up from 66 in Q1 2016.
- Funds reported $41.6M of CytRx Corp stock for Q2 2016, down 14% quarter-over-quarter.
- 13 funds opened new CytRx Corp positions in Q2 2016 and 6 closed out, a net change of +7 holders.
- The largest CytRx Corp buyer in Q2 2016 was Vanguard Group, an estimated $392K added.
- The largest CytRx Corp seller in Q2 2016 was QVT Financial, an estimated $1.18M sold.
Based on aggregated 13F filings for Q2 2016.